Montréal - Quebec | Canada
| Investor Type | Firm |
| Stages | Series C, Series B, Series A |
| Investing | Canada |
| Investment Range | $2,600,000 - $95,000,000 |
What is GeneChem (closed)?
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.
What are the investment firms similar to GeneChem (closed)
Khosla Ventures
Davidson Technology Growth Debt Fund
Ideavelopers
Algebra Ventures
Calm/Storm VC
QF Capital
Mosley Ventures
Amorchem
Gobi Ventures
Hi Inov - Dentressangle
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
